Table 2. The laboratory findings of MS patients and control groups.

*p < 0.05 is statistically significant.

MS: multiple sclerosis; HOMA-IR: Homeostatic Model Assessment Indicator of Insulin Resistance; HDL: high-density cholesterol; LDL: low-density cholesterol; VLDL: very low-density cholesterol; MOTS-c: mitochondrial open reading frame of the 12S rRNA-c

	MS (n = 43)	Control (n = 41)	P-value
	Mean ± SD	Mean ± SD
Glucose (mg/dL)	105.6 ± 30.56	92.34 ± 8.82	0.034*
Insulin (mU/L)	13.46 ± 10.06	9.03 ± 3.98	0.093
HOMA-IR	3.58 ± 2.82	2.08 ± 1.02	0.027*
Non-HDL cholesterol (mmol/L)	138.28 ± 39.12	128.44 ± 32.79	0.594
LDL cholesterol (mmol/L)	109.3 ± 30.26	102.59 ± 25.9	0.754
HDL cholesterol (mmol/L)	50.26 ± 11.69	53.29 ± 10.48	0.202
Total cholesterol (mmol/L)	187.28 ± 36.66	179.2 ± 31.93	0.71
Triglycerides (mmol/L)	138.14 ± 64.68	123.71 ± 69.46	0.263
VLDL cholesterol (mmol/L)	27.72 ± 13	25.41 ± 13.76	0.383
Folic acid (ug/L)	8.33 ± 3.39	8.73 ± 3.6	0.658
Vitamine B12 (ng/L)	393.76 ± 208.47	358.64 ± 103.86	0.904
MOTS-c	159.23 ± 40.79	189.95 ± 22.51	0.0001*